FDA NDC Directory · JSON-LD · Markdown

Divalproex Sodium

NDC 50268-259 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerAvPAK
Marketing categoryAbbreviated NDA (generic) · App ANDA203730
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsDIVALPROEX SODIUM (250 mg/1)
Marketing started20220916
Package count1

External sources

Source: openFDA. Public-domain (CC0).